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ABSTRACT 
Age Related Macular Degeneration (ARMD) is the leading cause of the vision loss and 
blindness in people above 50 years of age. ARMD is characterised by central vision loss, 
distorted or blurred vision, decreased visual acuity, Central or para-central blind spot 
(scotoma). An almost similar clinical condition to ARMD is seen in Pitta Vidagdha Dristi. 
Dry ARMD is more prevalent (90%) and slower in progress than Wet ARMD. The 
Ayurvedic management of Pitta Vidagdha Drishti is similar to Pittaja Abhishyanda. With 
this background a specific line of treatment for the Pitta Vidagdha Drisht in Sushruta 
Samhita is adopted. In this study, total 22 patients, 12 in group A (Triphala Ghrita, 
Saptamrita Lauha, Rasayana Churna and Shatavari etc.) & 10 in Group B (Control) were 
registered. The duration of therapy was of 3 months in both the groups. Group A showed 
better results on ARMD when compared with that of Group B especially on perception of 
flashes of light (72.23%) & dim light adaptation problem (45.23%). So ARMD (Dry type) 
can be better managed by Ayurvedic treatment group than the Modern multivitamin 
group. 
KEYWORDS: Age Related Macular Degeneration, Pitta Vidagdha Drishti, Nasya, Tarpana, 
Triphala Ghrita.  
INTRODUCTION 
Age related macular degeneration 
(ARMD) is a degenerative disease associated 
with aging that affects the macula and causes 
gradual loss of central vision, which is needed for 
seeing objects clearly in day to day activities. The 
disease is most often clinically apparent after 50 
years of age and is considered to be the leading 
cause of blindness in the developed and 
developing countries.33ARMD is the most 
common cause of irreversible visual loss which 
increases with age. The Indian prevalence has 
been reported as 1.1% from South India and 
4.7% in North Indian study.1 Dry ARMD is more 
prevalent (90%) and slower in progress than 
Wet ARMD. The most common causes of ARMD 
(Dry type) are sun light exposure, 
arteriosclerosis, smoking, oxidative damage, 
photic damage, inflammation, High fat intake etc. 
Drusen is the diagnostic sign and optical 
coherence tomography is the diagnostic tool for 
ARMD (Dry type).The diagnosis of ARMD is being 
increasingly made due to enhanced patient 
awareness, increased life expectancy, and path-
breaking innovation in medical equipment in 
diagnosis. The challenge therefore lies in 
preserving and improving existing vision by 
diagnosing and treating lesion at an even earlier 
stage. However, since none of the available 
treatment options are absolute in terms of 
efficacy and safety and also because of their high 
cost, it becomes very important to individualize 
therapy according to the patient and disease 
profile.1 
Pitta Vidagdha Drishti is a disease which 
comes under the Drishtigata Rogas- vision 
related diseases group of classification in 
Ayurvedic classics. In this disease, impairement of 
Drishti manifested as Vidagdhata caused by 
Vitiated Pitta. The word Vidagdhata in this 
context means partial destruction reflected as 
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functional impairment of visual apparatus / 
Drishti.2 
Tarpana is the foremost procedure for 
Drishtigata Rogas and provides Vata-Pitta 
Shamaka properties and nourishment to the eyes 
and improves visual acuity. Along with oral 
drugs, Nasya yoga is also described for Pitta 
Vidagdha Drishti because nose is the gateway of 
drug administration in case of Urdhwajatrugata 
Rogas. Till now no work on Pitta Vidagdha 
Drishti in context to ARMD has been done. So, an 
attempt is made to co-relate, access and manage 
the symptoms of Pitta Vidagdha Drishti w.s.r. to 
ARMD (Dry type).  
Drug selection 
 Though the aliment is a consequence of 
modern invention, Ayurveda, the ancient science 
of life can be great help in dealing the modern 
senile aliments by its preventive and therapeutic 
principles. Considering the Dosha involvement 
on the basis of symptom, Ayurvedic remedies can 
be used to treat the condition. Therapeutic 
measures like Kriyakalpa, Samana Aushadhes, 
Chakshusya and Rasayana, etc., which improve 
the homeostasis and ocular strength can be 
practised. Pitta Vidagdha Drishti can be managed 
by Ayurvedic Chakshusya and Vata-Pitta 
pacifying therapies. Triphala Ghrita5, Saptamrita 
Lauha6, Rasayana Churna7 and Shatavari8 are the 
formulations which have been extensively used 
for various eye disease and senile disorder. 
Triphala Ghrita selected for tarpana and 
Khirasharpi for Nasya in context to Pittaja 
Abhisyanda Chikitsa. All the drug are taken from 
the pharmacy of Gujarat ayurved university, 
Jamnagar, Gujarat.  
 Triphala Ghrita is used for both local and 
internal administration in many forms for 
treating many of the ocular conditions. 
 Triphala acts as the best Rasayana and 
Chakshusya drug without much discomfort.3 
Aims and Objectives 
The present study has been undertaken with the 
following aims and objectives - 
(1) To study the disease Pitta Vidagdha Drishti 
and ARMD conceptually and to trace the 
relation between the two. 
(2) To evaluate the efficacy of Ayurvedic 
treatment in dry type of ARMD. 
(3) To assess the toxic/adverse effect of the 
treatment if any. 
 
MATERIALS AND METHODS 
Patients 
 Patients attending the O.P.D. and I.P.D. of 
Department of Shalakya (Netra Roga unit), 
I.P.G.T. & R.A. hospital, G.A.U., Jamnagar with 
signs and symptoms of Age related macular 
degeneration (Pitta Vidagdha Drishti) were 
selected for the present study. 
Grouping 
 In the present study total 22 patients 
were registered and 21 patients completed the 
treatment i.e. 11 in group A and 10 in group B. In 
Group A & Group B, 1-1 patient had only one eye. 
So, total number of eyes in Group A was 21 and 
in Group B 19 eyes. 
Inclusion criteria 
Patients having signs and symptoms of 
ARMD (Dry type) / Pitta Vidagdha Drishti. 
Exclusion criteria 
(1) Patients having other ocular pathologies 
like glaucoma, high myopia, mature 
cataract, pan retinal degenerations etc. 
were excluded. 
(2) Patients having systemic diseases like 
hyper-cholesterolemia, renal disorder, 
liver disorder and other debilitating 
diseases.  
Criteria for diagnosis 
Subjective: (Refer Table: 1 for Gradation 
Index) 
(1) Difficulty in day vision 
(2) Diminished vision 
(3) Distorted vision 
(4) Perception of black spots in the field of 
vision 
(5) Perception of flashes of light 
(6) Perception of objects as yellowish 
(7) Problem for adaptation with dim light 
Table 1: Table showing Gradation Index  
Difficulty in Day Vision 
Grade 0 : No difficulty in day vision. 
Grade 1 : Difficulty in distance vision but 
no interference with routine 
work. 
Grade 2 : Occasionally interference with 
day to day working. 
Grade 3 : Cannot do any work in bright 
day light. 
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Diminished Vision 
Grade 0 : No diminished vision. 
Grade 1 : Dimness in vision but without 
imitating(inhibiting) activities 
Grade 2 : Sometime difficulty in 
performing routine work 
Grade 3 : Unable to go out independently. 
Distorted vision (This is assessed by using 
an Amsler’s grid) 
Grade 0 : No distorted vision 
Grade 1 : Lines are crooked or bent 
Grade 2 : Boxes appeared different in size 
and shape from each other 
Grade 3 : Boxes and Lines are wavy, 
missing. 
Perception of black spots 
Grade 0 : No perception of black spot. 
Grade 1 : Occasionally interfering with 
routine work. 
Grade 2 : Regular interfere with routine 
work. 
Grade 3 : Cannot perform routine work. 
Dark adaptation  
Grade 0 : Adaptation to darkness within 
few seconds 
Grade 1 : Slow dark adaptation within 10 
seconds 
Grade 2 : Slower dark adaptation within 
20 seconds 
Grade 3 : Slowest dark adaptation after 1 
minute 
     Xanthopsia: +ve/-ve  
    Perception of flashes of light: +ve/-ve 
Objective  
(1) Visual acuity 6/12 or less 
(2) Pin hole 6/18 or less 
(3) Fundus showing macular degeneration  
(4) Amsler’s Grid aberration 
(5) Ishihara’s colour vision testing 
(6) Optical coherence tomography  
Criteria of assessment 
Subjective 
Improvement in the subjective symptoms. 
Objectives 
(1) Improvement in distant vision 
(2) Improvement in pin hole 
(3) Improvement in the fundus changes  
(4) Optical Coherence Tomography changes 
(5) Amsler’s grid aberration changes  
 
 
GROUPING 
 Group 1- Treatment group - where in 
Ayurvedic treatment was given. 
 Group 2- Control group - where in 
antioxidant, multivitamin modern drug 
was given.  
              The research drug taken as standard 
control is tablet, which is a combination of vital 
anti-oxidants, minerals and vitamins. It contains  
 
Vitamin C 150mg 
Rutin 50mg 
Zinc oxide equivalents to 
element Zinc 
22 mg 
Vitamin B2 6 mg 
L-Glutathione 5 mg 
Manganese sulphate equivalent 
to elemental Manganese 
5 mg 
Lutein 2.5 mg 
Cupric oxide equivalent to 
elemental Copper 
2 mg 
Zeaxanthin 0.5 mg 
Sodium selenite equivalent to 
elemental Selenium 
55 mg 
Vitamin A (as bête carotene) 6000 IU 
Vitamin E (powder form) 50 IU 
Vitamin D3 200 IU 
DURATION: 3 months 
DRUGS & DOSES 
Group 1: A 5 days course of Deepana, 
Pachana, followed by Koshtha Shodhana with 
Erandabhristha Haritaki and then followed by 
the treatment. 
(1) For Nasya 
With Kshirasarpi9 (Milk cream)-3-3 drops  
(2) For Tarpana 
With Triphala Ghrita -10ml in each eye x 
1sitting 
(3) For internal use 
i) Rasayana Churna - 2 gm 
Saptamrita Lauha - 1 gm 
         Shatavari Churna - 2 gm 
   Along with Madhu at bed time. 
ii) Triphala Ghrita - 10ml at bed time with milk 
SCHEDULE OF NASYA & TARPANA: 
 Patient was subjected to undergo 1 
sitting of Nasya for 7 days, followed by 7 days of 
Tarpana in a month, with a gap of 7 days after 
Nasya and Tarpana. Pratimarsha Nasya was 
continued in between the post Nasya Karma 
interval periods and during the Akshi Tarpana 
karma. Rest six days giving only oral medication. 
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FOLLOW UP 
 1 month after the course of the treatment. 
Statistical Analysis 
The obtained data on the basis of 
observations were subjected to statistical 
analysis in terms of mean, standard deviation, 
standard error and ‘t’ test were conceded at the 
level of p<0.001 as highly significant, p<0.01 as 
significant, and p<0.05 as insignificant. 
CRITERIA FOR OVERALL ASSESSMENT OF 
EFFECT OF TREATMENT 
Assessment was done on the basis of 
special proforma through following. Scoring 
pattern and was analyzed statistically with the 
help of P value. 
Cured: 100 % relief of the complaints and no 
recurrence during the follow up. 
Marked improvement: 75% and up to 100% 
relief in the complaints. 
Moderate improvement: 50% and up to 75% 
relief in the complaints. 
Mild improvement: 25% and up to 50% relief 
in the complaints. 
Unchanged: less than 25% relief in the 
complaints. 
OBSERVATIONS 
In the study, maximum patients 
i.e.86.37% were above 50 years of age, 68.18% 
were males, 77.27% were from urban areas,50% 
belonged to lower middle class, 77.27% were 
vegetarians, 54.55% had regular bowel habit, 
77.27% had normal maturation, 63.64% had 
disturbed sleep, 100% patients were habituated 
to tea, 45.45% patients had a chronicity of 1-2 
years, history of prolonged sunlight exposure 
and past ocular history could be cited in 59.09% 
and 36.36% patients respectively. Maximum 
patients (63.64%) had Vata-Pitta Prakriti. On 
chief complaints, majority all patients had 
difficulty in day vision and diminished vision, 
88.10% patients had perception of flashes of 
light, 95.24% had problem for adaptation with 
dim light, 26.19% had distorted vision and 
21.43% patients had perception of black spots in 
the field of vision. 
Maximum patient’s i.e. 21.43% had visual 
acuity of 6/18 and 6/60 or less, 26.19% and 
21.43% patients had visual acuity for pinhole of 
6/60 or less and 6/18 respectively. Distant 
vision and near vision best corrected was found 
6/18(30.95%) and N/8 (59.52%) respectively. 
On fundus examination and OCT all patients had 
pathological changes in the macula and general 
background (100%). In Amsler’s grid chart 
maximum i.e. 73.81% patients had normal 
findings.  
DISCUSSION 
Effect on Group A-Trial group on chief 
complaints of 11 patient’s eye of ARMD (Pitta 
Vidagdha Drishti) 
Right eye 
 Statistically insignificant results were 
observed in the relief of difficulty in day 
vision. 
 Insignificant clinical improvement was 
observed in distorted vision while assessing 
the effect in 04 eyes (33.33%). 
 22.22% relief was found clinically in 
perception of black spots in the field of 
vision in 06 eyes. This value is statistically 
insignificant at the level p<0.10. 
 While assessing the effect in 09 eyes, highly 
significant clinical improvement was 
observed in perception of flashes of light 
(66.67%). 
 Statistically highly significant results were 
observed in the relief of problem for 
adaptation with dim light (p<0.001).  
 Statistically results were not applicable in 
diminished vision & perception of objects as 
yellowish. 
Left eye 
 Statistically insignificant results were 
observed in the relief of difficulty in day 
vision (18.75%), diminished vision (8.33%), 
perception of black spots in the field of 
vision (25.00%) and distorted vision 
(50.00%).  
 Highly significant clinical improvement was 
observed in perception of flashes of light 
(77.78%) and problem for adaptation with 
dim light (45.00%) 
 Statistically results were not applicable in 
perception of objects as yellowish. 
Effect on Group B-Control group on chief 
complaints of 10 patient’s eye of ARMD 
(Pitta Vidagdha Drishti) 
Right eye 
 Insignificant clinical improvement was 
observed in diminished vision while 
assessing the effect in 10 eyes (6.25%). 
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 Statistically insignificant results were 
observed in the relief of perception of 
flashes of light. 
 6.25 % relief was found clinically in 
problem for adaptation with dim light in 09 
eyes. This value is statistically insignificant 
at the level p<0.10. 
 Statistically results were not applicable in 
difficulty in day vision, distorted vision, 
perception of black spots in the field of 
vision & perception of objects as yellowish.  
Left eye 
 Statistically insignificant results were 
observed in the relief of difficulty in day 
vision (12.50%), diminished vision 
(14.29%), distorted vision (33.33%), 
perception of black spots in the field of 
vision (37.50%) and problem for adaptation 
with dim light (7.14%). 
 Statistically results were not applicable in 
perception of objects as yellowish and 
Perception of black spots in the field of 
vision. 
Effect of Group A-Trial group on Amsler’s grid 
chart of 11 patients of ARMD/PVD 
 Statistically insignificant results were 
observed in the Rt eye (50.00%) and Lt eye 
(25.00%). 
Effect of Group B-Control group on Amsler’s 
grid chart of 10 patients of ARMD/PVD 
 Statistically insignificant result in Lt eye 
(33.33%) and results were not applicable in 
Rt eye. 
Table 2: Effect of Group A-Trial group on OCT of 11 patients of ARMD/PVD 
Group A No. of Eyes Mean Mean ± SE % S.D. ‘t’ P 
BT AT 
RE 11 1.00 0.64 0.36 ± 0.15 36.36 0.50 2.39 >0.02 
LE 10 1.00 0.60 0.40 ± 0.16 40.00 0.52 2.45 >0.02 
 Statistically significant result in Rt eye (36.36%) and Lt eye (40.00%). 
Table 3: Effect of Group B-Control group on OCT of 10 patients of ARMD/PVD 
Group B No. of Eyes Mean Mean ± SE % S.D. ‘t’ P 
BT AT 
RE 10 1.00 1.00 0.00 ± 0.00 0.00 0.00 NA  
LE 09 1.00 1.00 0.00 ± 0.00 0.00 0.00 NA  
 Statistically results were not applicable in OCT in control group. 
Table 4: Overall effect of therapy Group A 
No. of Eyes Mean Mean ± SE % S.D. ‘t’ P 
BT AT 
21 23.10 19.43 3.67 ± 0.60 15.88 2.74 6.12 <0.001 
 There was 15.88% of improvement in the symptom with t-value 6.12, which is statistically 
highly significant at p<0.001. 
Table 5: Overall effect of therapy Group B 
No. of Eyes Mean Mean ± SE % S.D. ‘t’ P 
BT AT 
19 22.60 21.90 0.70 ± 0.18 3.10 0.80 3.81 <0.01 
 There was 3.10% of improvement in the symptom with t-value 3.81, which is statistically 
significant at p<0.01. 
Table 6: Comparative overall effect of Group A and Group B 
No. Of Eyes % relief Diff of means ‘t’ P 
Group A Group B 
40 15.88 3.10 3.035 4.656 <0.001 
 Group A showed better results on ARMD when compared with that of Group B. The difference 
was statistically highly significant with the ‘t’ 4.656. (p<0.001) 
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Pitta Vidagdha Drishti has drawn attention 
of ancient physicians which is evident from the 
fact that its description, symptomatology and 
management are available in literature. Even 
though the disease Pitta Vidagdha Drishti has 
been considered as a curable disease if the 
treatment is given well in time otherwise the 
disease results in further deterioration and 
ultimately blindness ensues. 
The mode of action of the drug can be 
understood based on the inherent properties of 
all the drugs. 
The clinical trial drugs have 
predominance of Madhura (81.81%), Kashaya 
(63.63%), Tikta (45.45%) and Katu Rasa 
(27.27%), Ruksha Guna (45.45%), Guru Guna 
(36.36%), Laghu Guna (36.36%) and Snigdha 
Guna (36.36%), Sheeta Virya (63.63%) & Ushna 
Veerya (36.36%) and Madhura Vipaka (100%).  
Considering the Doshakarma, the trial 
drugs are Tridosha Shamaka (45.45%), Pitta 
Shamaka (18.18%), Kapha Shamaka (27.27%), 
Vata-Pitta Shamaka (9.09 %) and Rakta-Pitta 
Samaka (9.09%) by virtue of its Rasa, Guna, 
Virya and Vipaka. Thus, the overall effect of the 
compound drug is Tridosha Shamaka and hence 
it disintegrates the pathology of the disease Pitta 
Vidagdha Drishti, which is Pitta-Vata dominant 
in its manifestation. 
Most of the drugs of Triphala Ghrita, 
Rasayana Churana, Saptamrita Lauha, Satawari 
are Anti-oxidant, immunomodulatory, Free 
radical scavenging effect, hypoglycaemic, 
adaptogenic, hypocholesterolaemic, capillary 
strengthening, anti-atherosclerotic effect4. So, it 
is direct effect on disease pathology and relieves 
the symptoms. As a result of the action of the 
drug, it is assumed that the drug is effective in 
breaking down the aetiopathogenesis of the 
disease. 
CONCLUSION 
 Incidence of disease is common in 
Geriatric patients i.e. Vriddhavastha. Vata – Pitta 
Prakopaka Nidana has a vital role in disease 
pathogenesis of Pitta Vidagdha Drishti. 
Dhumanishevanat (smoking) & 
Ushnaabhitaptasya /Atapa sevana /Baskara 
darshana (excessive sunlight exposure) play a 
major role as a risk factor in ARMD/ Pitta 
Vidagdha Drishti. Kopa, Shoka Manasika Bhavas 
also play a important role in causing & 
progression of ARMD/ Pitta Vidagdha Drishti. 
Excessive exposure to sunlight may be the 
reason for Drishti Vidagdhata. Drusen is a 
pathognomic sign for ARMD (Dry type). 
According to literature, the pathogenesis of 
ARMD (Dry type) and Pitta Vidagdha Drishti is 
almost similar. Features of 3rd Patalagata Timira 
are also related with retinal disorders. Divam na 
pashyati, Drishti Peeta varnani, Nisham cha 
pashyati - these features are strongly in co-
relation with the symptoms and signs of ARMD 
(Dry type). But, we can also say that ARMD is a 
part of Pitta Vidagdha Drishti. Sharira - VP 
prakriti and Rajashika Manas prakriti 
contributes a major role for the disease 
pathology. Vidaha / degeneration of Drishti 
(Retina/Macula) is suggestive of Pitta- Vata 
pathology at Alochaka Pitta site. Age and Risk 
factors are main causes. So, only external 
medicine is not sufficient to cure ARMD (Dry 
type). On observing the effect of therapy in 
symptoms like perception of flashes of light 
(72.23%) & dim light adaptation problem 
(45.23%) in ARMD (Dry type) can be better 
managed by Ayurvedic treatment group than the 
Modern multivitamin group. Modern 
ophthalmology does not have FDA approved 
treatment modality till date whereas Ayurveda 
has elaborated on treatment principle and 
therapeutic procedures of Pitta Vidagdha Drishti 
thousands of years back. Patient who had 6/60 
DVA, did not improve with pin hole after giving 
best correction. It suggests that in advanced 
stages of ARMD (Dry type) bringing back vision 
normalcy is not possible. It reflects that the 
degenerative process in initial phase only can be 
reversed to some extent by Ayurvedic treatment. 
Effect of therapy may be due to Dipana and 
Koshtha Shodhana followed by Shamana therapy 
with Kshirasarpi Nasya & Tarpana with Triphala 
Ghrita (Urdhvanga Snehana) which is Pitta 
Shamaka, Brimhana and Rasayana. Maximum 
result is not only due to internal use of drugs, 
Triphala Ghrita, Saptamrita Lauha, and Rasayana 
Churna, but topical use of Tarpana with Triphala 
Ghrita & Nasya with Kshirasarpi has major role 
to reverse the pathology of ARMD (Dry type) to 
some extent. 
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